Recombinant MET (Davutamig Biosimilar) antibody

Catalog No. ABIN7597616

The Human Monoclonal anti-MET (Davutamig Biosimilar) antibody (ABIN7597616) specifically detects MET (Davutamig Biosimilar). The antibody is reactive with Human samples.

Quick Overview for Recombinant MET (Davutamig Biosimilar) antibody (ABIN7597616)

Target: MET (Davutamig Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Grade: Research Grade

Product Details

Expression System: Mammalian cells

Purpose: Research Grade Davutamig Biosimilar Antibody

Specificity: Tyrosine-protein kinase Met, Hepatocyte growth factor receptor, Proto-oncogene c-Met, Scatter factor receptor, HGF receptor, SF receptor, HGF/SF receptor, MET

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG4 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details

Target: MET (Davutamig Biosimilar)

Alternative Name: Davutamig Biosimilar

Target Type: Biosimilar

Background: Tyrosine-protein kinase Met, Hepatocyte growth factor receptor, Proto-oncogene c-Met, Scatter factor receptor, HGF receptor, SF receptor, HGF/SF receptor, MET

UniProt: P08581

CAS-No: 2648058-48-2